Olanzapine or Lamotrigine Addition to Lithium in Remitted Bipolar Disorder Patients With Anxiety Disorder Comorbidity: A Randomized, Single-Blind, Pilot Study
The DOI matches its Crossref record.
Abstract
OBJECTIVE: The aim of the present randomized, single-blind, pilot study was to assess the efficacy of the addition of a second mood stabilizer, either olanzapine or lamotrigine, to lithium in patients with remitted bipolar disorder and comorbid anxiety disorder. METHOD: Adult DSM-IV bipolar disorder patients with a current anxiety disorder and a Hamilton Rating Scale for Anxiety (HAM-A) score of 12 or higher, in remission from an affective episode for at least 2 months while on lithium maintenance treatment, were randomly assigned to receive 12 weeks of single-blind olanzapine 5 to 10 mg/day (N = 24) or lamotrigine 50 to 200 mg/day (N = 23) addition to lithium. The primary outcome measure was the HAM-A; secondary outcome measures were the Clinical Global Impressions-Severity of Illness scale and the Global Assessment of Functioning (GAF) scale. Data were collected from July 2005 to February 2007. RESULTS: Twenty-two patients in the olanzapine and 18 in the lamotrigine group completed the trial. Mean +/- SD final doses of olanzapine and lamotrigine were, respectively, 7.7 +/- 4.2 mg/day and 96.7 +/- 46.7 mg/day in the intent-to-treat sample (N = 47). Both olanzapine and lamotrigine were effective in reducing HAM-A scores from baseline to endpoint (paired t test for completers: t = 11.361, df = 21, p < .001 for olanzapine and t = 6.301, df = 17, p < .001 for lamotrigine). Both drugs were also effective on the secondary outcome measures. Olanzapine was more effective than lamotrigine at weeks 6 and 12 with a last-observation-carried-forward analysis on all 3 outcome measures, while such differences disappeared on the HAM-A and GAF at week 12 with the visit-wise analysis. CONCLUSIONS: The addition of a second mood stabilizer (olanzapine or lamotrigine) to lithium is effective in reducing anxiety symptoms in bipolar disorder patients with a co-occurring anxiety disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For patients who are euthymic and treated with lithium, the addition of lamotrigine or olanzapine has demonstrated similar anxiolytic effects (level 3).728”
Citations
Cites
Still being checked.
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., et al. (2013) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,217
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“in anxiety disorder symptoms in patients with remitted bipolar disorder [1408]; and in an open trial, switching to”
BackgroundYatham, L. N., Kennedy, S. H., Schaffer, A., Parikh, S. V., Beaulieu, S., O'Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., Ravindran, A., et al. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00672.x · Cited by 570
Ramasubbu, R., Taylor, V. H., Samaan, Z., Sockalingham, S., Li, M., Patten, S., Rodin, G., Schaffer, A., Beaulieu, S., & McIntyre, R. S. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400110 · Cited by 206
Comorbidity of bipolar and anxiety disorders: An overview of trends in research
Spoorthy, M. S., Chakrabarti, S., & Grover, S. (2018) · World Journal of Psychiatry · doi:10.5498/wjp.v9.i1.7 · Cited by 138
Vázquez, G. H., Baldessarini, R. J., & Tondo, L. (2014) · Depression and Anxiety · doi:10.1002/da.22248 · Cited by 93
Treatment‐resistant bipolar depression: towards a new definition
Pacchiarotti, I., Mazzarini, L., Colom, F., Sanchez‐Moreno, J., Girardi, P., Kotzalidis, G. D., & Vieta, E. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01471.x · Cited by 74
Treatment of Bipolar Disorder in a Lifetime Perspective: Is Lithium Still the Best Choice?
Sani, G., Perugi, G., & Tondo, L. (2017) · Clinical Drug Investigation · doi:10.1007/s40261-017-0531-2 · Cited by 75
Malhi, G. S., Adams, D., Cahill, C. M., Dodd, S., & Berk, M. (2009) · Drugs · doi:10.2165/11318850-000000000-00000 · Cited by 64
The clinical management of bipolar disorder complexity using a stratified model
Malhi, G. S., Bargh, D. M., Cashman, E., Frye, M. A., & Gitlin, M. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.00993.x · Cited by 49
Epidemiology and Management of Anxiety in Patients with Bipolar Disorder
Kauer‐Sant’Anna, M., Kapczinski, F. P., & Vieta, E. (2009) · CNS Drugs · doi:10.2165/11310850-000000000-00000 · Cited by 46
Anxiety Disorder Comorbidity in Bipolar Disorder, Schizophrenia and Schizoaffective Disorder
Young, S., Pfaff, D., Lewandowski, K. E., Ravichandran, C., Cohen, B. M., & Öngür, D. (2013) · Psychopathology · doi:10.1159/000339556 · Cited by 40
Comorbidities in Youth with Bipolar Disorder: Clinical Features and Pharmacological Management
Sesso, G., Brancati, G. E., & Masi, G. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220706104117 · Cited by 39
Bobo, W. V., Reilly-Harrington, N. A., Ketter, T. A., Brody, B. D., Kinrys, G., Kemp, D. E., Shelton, R. C., McElroy, S. L., Sylvia, L. G., Kocsis, J. H., et al. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000257 · Cited by 27
Polypharmacy as maintenance treatment in bipolar illness: A systematic review
Amerio, A., Russo, D., Miletto, N., Aguglia, A., Costanza, A., Benatti, B., Odone, A., Barroilhet, S. A., Brakoulias, V., Dell’Osso, B. M., et al. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13312 · Cited by 24
Treatment of anxiety disorders in patients with comorbid bipolar disorder
Ott, C. A. (2018) · Mental Health Clinician · doi:10.9740/mhc.2018.11.256 · Cited by 24
de Filippis, R., Aguglia, A., Costanza, A., Benatti, B., Placenti, V., Vai, E., Bruno, E., Berardis, D. D., Dell’Osso, B. M., Albert, U., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051230 · Cited by 21
Self-citationPractice Guidelines for Bipolar Disorder by the JSMD (Japanese Society of Mood Disorders)
Kato, T., Ogasawara, K., Motomura, K., Kato, M., Tanaka, T., Takaesu, Y., Nio, S., Kishi, T., So, M., Nemoto, K., et al. (2024) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13724 · Cited by 21
Schoenknecht, P., Traenkner, & Sander (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s37126 · Cited by 16
Crapanzano, C., Damiani, S., & Guiot, C. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001420 · Cited by 16
Troubles bipolaires et troubles anxieux comorbides : impact pronostique et enjeux therapeutiques
Cazard, F., & Ferreri, F. (2012) · L Encéphale · doi:10.1016/j.encep.2012.04.005 · Cited by 16
Seeberg, I., Nielsen, I., Jørgensen, C., Eskestad, N., & Miskowiak, K. W. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.119 · Cited by 16
Comorbid anxiety in depression and rTMS treatment response: A retrospective study
Kazemi, R., Rostami, R., Rezaei, M., Hedayati, S., Khomami, S., & Hadipour, A. L. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.01.148 · Cited by 15
Anxiety and bipolar disorders: epidemiological and clinical aspects
Maina, G., Rosso, G., Aguglia, A., Chiodelli, D. F., & Bogetto, F. (2011) · Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology · Cited by 15
Self-citationSafety and tolerability of anticonvulsant medication in bipolar disorder
Pichler, E. M., Hattwich, G., Grunze, H., & Muehlbacher, M. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1088001 · Cited by 15
Lessons from STEP-BD for the treatment of bipolar depression
Nierenberg, A. A. (2009) · Depression and Anxiety · doi:10.1002/da.20547 · Cited by 13
Treatment of Comorbid Psychiatric Disorders with Bipolar Disorder
Altınbaş, K. (2021) · Nöro Psikiyatri Arşivi · doi:10.29399/npa.27615 · Cited by 11
Clinical practice guidelines for the management of bipolar disorder: 2025 update
Menon, V., Ganesh, R., Deep, R., Sarkhel, S., Goswami, S., Mohapatra, D., Munoli, R. N., Sharma, P., Reddy, M., & Muralidharan, K. (2026) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry_1186_25 · Cited by 10
Aripiprazole Augmentation to Mood Stabilizers for Obsessive-Compulsive Symptoms in Bipolar Disorder
Salvo, G. D., Maina, G., Pessina, E., Teobaldi, E., Barbaro, F., Martini, A., Albert, U., & Rosso, G. (2020) · Medicina · doi:10.3390/medicina57010009 · Cited by 10
Self-citationBipolar (Manic Depressive) Disorders
El‐Mallakh, R. S., & Bauer, M. S. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch49 · Cited by 10
Pan, P.-Y., Lee, M.-S., Lo, M.-C., Yang, E.-L., & Yeh, C.-B. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-145 · Cited by 9
Schaffer, A., McIntosh, D., Goldstein, B. I., Rector, N. A., McIntyre, R. S., Beaulieu, S., Swinson, R., & Yatham, L. N. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400103 · Cited by 7
“41 In the other RCT, risperidone monotherapy (mean dose, 2.5 mg) was found to be no more effective than placebo in reducing anxiety symptoms for patients with BD I, BD II, or BD not otherwise specified (NOS) and comorbid GAD or PD (N = 111) 42 (level 2 – negative).”
InfluentialBauer, M., Glenn, T., Grof, P., Rasgon, N., Marsh, W., Sagduyu, K., Alda, M., Lewitzka, U., Schmid, R., & Whybrow, P. C. (2008) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651500802450514 · Cited by 6
Seo, J. S., Jamieson, K., Cosgrove, V. E., Gwizdowski, I. S., Yang, H., Sheehan, D. V., McElroy, S. L., & Suppes, T. M. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2011.08.001 · Cited by 6
Komaki, S., Amiri, P., Safari, S., Oshaghi, E. A., Ramezani‐Aliakbari, F., Golipoor, M., Kourosh‐Arami, M., Rashno, M., & Komaki, A. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1376074 · Cited by 5
Management of Comorbidity in Bipolar Disorder
Salloum, I. M., Pani, L., & Cooke, T. (2010) · Wiley eBooks · doi:10.1002/9780470661277.ch27 · Cited by 5
Wang, Y., Liu, J., Zhang, R., Luo, G., & Sun, D. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-024-02876-x · Cited by 3
Olanzapine enhances anxiety response to an SSRI in a woman with bipolar disorder
Sepede, G., Gambi, F., ONOFRJ, M. C., Giannantonio, M. D., & Salerno, R. M. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.11.015 · Cited by 2
Disturbi bipolari e d'ansia: aspetti epidemiologici e clinici
Maina, G., Rosso, G., Aguglia, A., Chiodelli, D. F., & Bogetto, F. (2011) · CINECA IRIS Institutial Research Information System (University of Genoa) · Cited by 2
Self-citation日本神経精神薬理学会, 日. /. (2025) · Anxiety Disorder Research · doi:10.14389/jsad.17.1_22 · Cited by 1
The Nature and Treatment of Bipolar Disorder and the Bipolar Spectrum
Otto, M. W., & Applebaum, A. J. (2014) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780199328710.013.035 · Cited by 1
Yang, L., Yan, M., Du, L., Hu, S., & Zhang, Z. (2020) · Medicine · doi:10.1097/md.0000000000022280 · Cited by 1
Évolution des symptômes anxieux lors des épisodes thymiques et de leur traitement
Groulier, M. (2016) · HAL · Cited by 1
Practical Pharmacological Maintenance Treatment of Bipolar Disorder
Swann, A. C. (2010) · Wiley eBooks · doi:10.1002/9780470661277.ch24
Recent Progress in the Pharmacotherapy of Bipolar Disorder
Mitchell, P. B., Loo, C. K. A., & Breakspear, M. J. (2009) · Future Neurology · doi:10.2217/fnl.09.18
Il trattamento del disturbo ossessivo-compulsivo resistente
Aguglia, A., Albert, U., Cori, D. D., Maina, G., & Bogetto, F. (2011) · Quaderni Italiani di Psichiatria · doi:10.1016/j.quip.2010.12.003
Self-citationA Patient with Bipolar-II Disorder
Baig, M. R., Kommor, M. J., & Bhanot, V. K. (2009) · Psychiatric Annals · doi:10.3928/00485713-20090924-01
Pereira, V. C. M. (2017) · UFPR Digital Collection (Federal University of Paraná)
Current awareness in human psychopharmacology
(2008) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.892
Nosographic classification of mood disorders: from symptoms to diagnosis and treatment
Albert, U., Aguglia, A., Barbaro, F., Maina, G., & Bogetto, F. (2012) · Reviews in Health Care · doi:10.7175/rhc.v3i3.200
Self-citationWang, J. (2023) · Open Journal of Medical Psychology · doi:10.4236/ojmp.2023.122006
Prioritizing the Components of Any Decision-Making Model
Goldberg, J. F., & Stahl, S. M. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009181549.012
From systems thinking to P4 medicine
Hedayat, K. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-22326-6.00022-5
Troubles anxieux et troubles bipolaires
Godier, É., Dejean, D., Ifrah, G., & Gohier, B. (2023) · Elsevier eBooks · doi:10.1016/b978-2-294-77180-4.00031-7
日本神経精神薬理学会, 日. /. (2021) · Anxiety Disorder Research · doi:10.14389/jsad.13.1_53
Sindrome metabolica nel disturbo bipolare: prevalenza, evoluzione e rischio di suicidio
D'ambrosio, V. (1978) · OpenstarTs (Univeristy of Trieste https://www.units.it/)
Aumento di peso e sindrome metabolica nel disturbo bipolare
Salvi, V. (1974) · OpenstarTs (Univeristy of Trieste https://www.units.it/)
日本神経精神薬理学会, 日. /. (2025) · Anxiety Disorder Research · doi:10.14389/jsad.17.1_112
Somatic Symptom Disorder Improved With Lamotrigine
Petridis, P. D. (2026) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000002287
Metadata
- Authors
- Maina, G., Albert, U., Rosso, G., & Bogetto, F.
- Affiliations
- University of Turin (IT)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2008-04-15
- Volume
- 69
- Issue
- 4
- Pages
- 609-616
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1969729851
- Cited by
- 50
- References
- 0
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 1 · 2021: 2 · 2020: 3 · 2018: 3 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 4 · 2013: 2 · 2012: 5
- FWCI
- 3.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- bipolar disorder, anxiety disorder comorbidity, olanzapine, lamotrigine, lithium, adjunctive therapy, remitted bipolar disorder, anxiety symptoms
- MeSH terms
- Olanzapine, Lamotrigine, Adolescent, Adult, Aged, Anxiety Disorders, Benzodiazepines, Bipolar Disorder, Drug Administration Schedule, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Pilot Projects, Antipsychotic Agents, Triazines, Comorbidity, Single-Blind Method, Lithium Carbonate, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.